SARS-CoV-2, Zapnometinib, host-targeted antiviral, direct-acting antiviral, drug resistance
"Culture-independent techniques", "Ghanaian substrates", "Microbial diversity", "Probiotic bacteria", "Spontaneous fermentation", "16S rDNA sequencing", "Microbiome"
Escherichia coli, enteropathogenic E. coli, EPEC, pathogenicity islands, LEE, effector repertoire